[Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis].
Rieckmann
P
P
Moriabadi
N
N
Flachenecker
P
P
Toyka
K
K
D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007121:Immunocompetence / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D009103:Multiple Sclerosis / Q000276:immunology*; D012307:Risk Factors
D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines